Novitas, the US Medicare Administrative Contractor, delays making final decision on removing Cxbladder from its approved test list.
UPDATE: MPI provides fruit-growers with new rules as court deadline loomed.
The company has been thwarted in its ambitions by underinvestment and has lost touch with consumers.
The boosts for building efficiency are clear but what about the unintended consequences?
Methven shares jumped 7.2% to $1.19 after the announcement.
Block trade disclosed to NZX
GDT suffers from an unexpected dip in key products.
Christchurch-based visual data science company draws in Accel-KKR for growth investment.
Investors into NZ's only annuities provider include Oriens Capital and Gareth Morgan.
Slight slip in US stocks as worry emerging markets contagion could spread to developed markets.